109 related articles for article (PubMed ID: 10879185)
1. [Magnetic drug delivery system--adriamycin-carboxymethyl dextran magnetic nanoparticles].
Shi K; Li C; He B
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2000 Mar; 17(1):21-4. PubMed ID: 10879185
[TBL] [Abstract][Full Text] [Related]
2. [Studies on the toxic effects of magnetic targeting adriamycin-carboxymethyldextran magnetic nanoparticles].
Shi K; Li C; He B
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Jun; 20(2):219-21. PubMed ID: 12856583
[TBL] [Abstract][Full Text] [Related]
3. Polybutylcyanoacrylate magnetic nanoparticles as carriers of adriamycin.
Cai L; Niu G; Hu Z; Jin W; Wang J; Sun L
J Drug Target; 2009 Apr; 17(3):200-6. PubMed ID: 19558359
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo evaluation of targeting efficiency of Adriamycin hydrochloride magnetic microspheres.
Peng B; Yang X; Li X; Pan H; Zhang Z; Liu H; Ma S; Pan W
Drug Deliv; 2011 Feb; 18(2):166-72. PubMed ID: 21047168
[TBL] [Abstract][Full Text] [Related]
5. Bioreducible carboxymethyl dextran nanoparticles for tumor-targeted drug delivery.
Thambi T; You DG; Han HS; Deepagan VG; Jeon SM; Suh YD; Choi KY; Kim K; Kwon IC; Yi GR; Lee JY; Lee DS; Park JH
Adv Healthc Mater; 2014 Nov; 3(11):1829-38. PubMed ID: 24753360
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery.
Unsoy G; Khodadust R; Yalcin S; Mutlu P; Gunduz U
Eur J Pharm Sci; 2014 Oct; 62():243-50. PubMed ID: 24931189
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo study of Gal-OS self-assembled nanoparticles for liver-targeting delivery of doxorubicin.
Guo H; Zhang D; Li T; Li C; Guo Y; Liu G; Hao L; Shen J; Qi L; Liu X; Luan J; Zhang Q
J Pharm Sci; 2014 Mar; 103(3):987-93. PubMed ID: 24549734
[TBL] [Abstract][Full Text] [Related]
8. Antitumor effect of adriamycin-encapsulated nanoparticles of poly(DL-lactide-co-glycolide)-grafted dextran.
Choi KC; Bang JY; Kim C; Kim PI; Lee SR; Chung WT; Park WD; Park JS; Lee YS; Song CE; Lee HY
J Pharm Sci; 2009 Jun; 98(6):2104-12. PubMed ID: 18823029
[TBL] [Abstract][Full Text] [Related]
9. In vivo multimodality imaging of miRNA-16 iron nanoparticle reversing drug resistance to chemotherapy in a mouse gastric cancer model.
Sun Z; Song X; Li X; Su T; Qi S; Qiao R; Wang F; Huan Y; Yang W; Wang J; Nie Y; Wu K; Gao M; Cao F
Nanoscale; 2014 Nov; 6(23):14343-53. PubMed ID: 25327162
[TBL] [Abstract][Full Text] [Related]
10. Polyhydroxybutyrate-coated magnetic nanoparticles for doxorubicin delivery: cytotoxic effect against doxorubicin-resistant breast cancer cell line.
Yalcin S; Unsoy G; Mutlu P; Khodadust R; Gunduz U
Am J Ther; 2014; 21(6):453-61. PubMed ID: 25137407
[TBL] [Abstract][Full Text] [Related]
11. Carboxymethyl dextran-cyclodextrin conjugate as the carrier of doxorubicin.
Sivasubramanian M; Thambi T; Deepagan VG; Saravanakumar G; Ko H; Kang YM; Park JH
J Nanosci Nanotechnol; 2013 Nov; 13(11):7271-8. PubMed ID: 24245242
[TBL] [Abstract][Full Text] [Related]
12. Pegylated magnetic nanocarriers for doxorubicin delivery: a quantitative determination of stealthiness in vitro and in vivo.
Allard-Vannier E; Cohen-Jonathan S; Gautier J; Hervé-Aubert K; Munnier E; Soucé M; Legras P; Passirani C; Chourpa I
Eur J Pharm Biopharm; 2012 Aug; 81(3):498-505. PubMed ID: 22510695
[TBL] [Abstract][Full Text] [Related]
13. pH-sensitive pullulan-based nanoparticle carrier for adriamycin to overcome drug-resistance of cancer cells.
Guo H; Liu Y; Wang Y; Wu J; Yang X; Li R; Wang Y; Zhang N
Carbohydr Polym; 2014 Oct; 111():908-17. PubMed ID: 25037431
[TBL] [Abstract][Full Text] [Related]
14. [Effect of diameter of adriamycin polybutylcyanoacrylate nanoparticles on liver targeting].
Shen LF; Wang X; Wang C; Zhao K; Liu XJ; Shen HJ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 31(5):732-6, 741. PubMed ID: 17062941
[TBL] [Abstract][Full Text] [Related]
15. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z
J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560
[TBL] [Abstract][Full Text] [Related]
16. Construction of doxorubicin-loading magnetic nanocarriers for assaying apoptosis of glioblastoma cells.
Wang X; Wang L; Tan X; Zhang H; Sun G
J Colloid Interface Sci; 2014 Dec; 436():267-75. PubMed ID: 25280371
[TBL] [Abstract][Full Text] [Related]
17. Magnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imaging.
Jain TK; Richey J; Strand M; Leslie-Pelecky DL; Flask CA; Labhasetwar V
Biomaterials; 2008 Oct; 29(29):4012-21. PubMed ID: 18649936
[TBL] [Abstract][Full Text] [Related]
18. Selective delivery of adriamycin to a solid tumor using a polymeric micelle carrier system.
Yokoyama M; Okano T; Sakurai Y; Fukushima S; Okamoto K; Kataoka K
J Drug Target; 1999; 7(3):171-86. PubMed ID: 10680973
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of anti-tumor activity of hybrid peptide in conjugation with carboxymethyl dextran via disulfide linkers.
Gaowa A; Horibe T; Kohno M; Tabata Y; Harada H; Hiraoka M; Kawakami K
Eur J Pharm Biopharm; 2015 May; 92():228-36. PubMed ID: 25801495
[TBL] [Abstract][Full Text] [Related]
20. In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation.
Chen Y; Yang W; Chang B; Hu H; Fang X; Sha X
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):406-12. PubMed ID: 23816639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
